Amy Dawn Brockmeyer, MD Obstetrics & Gynecology - Gynecologic Oncology Medicare: Accepting Medicare Assignments Practice Location: 2949 E Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4734 |
Andrea Michelle Langford, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1489 S Higley Rd Ste 101, Gilbert, AZ 85296 Phone: 480-571-1554 |
Dr. Phillip Garza, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3367 S Mercy Rd Ste 207, Gilbert, AZ 85297 Phone: 480-855-5900 Fax: 480-855-9171 |
Dr. Rebecca Conrad Dominguez, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5656 S Power Rd, Suite 137, Gilbert, AZ 85295 Phone: 480-821-3616 Fax: 480-857-2667 |
Alexandra Mcdaniel, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1760 E Pecos Rd Ste 516, Gilbert, AZ 85295 Phone: 480-821-3600 Fax: 480-857-2667 |
Aleze Krumholz, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2550 E Guadalupe Rd Ste 109, Gilbert, AZ 85234 Phone: 480-505-4475 Fax: 480-505-4252 |
News Archive
In 2010, almost 50 million couples worldwide were unable to have a child after five years of trying. Infertility rates have hardly changed over the past 20 years, according to a study by international researchers published in this week's PLOS Medicine.
Researchers develop a simulation model to characterize the risks and uncertainties associated with infections from aerosol exposure during in-person classes.
Spectrum Pharmaceuticals has announced that it has received from the U.S. Patent and Trademark Office (USPTO) a Notice of Allowance for its patent application for SPI-339 entitled "Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives."
BSD Medical Corporation today reported publication of an article on BSD's pioneering development of sophisticated technology to improve the delivery of heat therapy for the treatment of certain cancerous tumors.
A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy.
› Verified 4 days ago